Publications by authors named "Hebatallah Hamed Ali"
Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts.
Ibrahim Almaghlouth Kawther Ghassan Bohuliga Boshra Alanazi Bushra Khaled Alhawsa Abdulaziz Mohammed Alabdulkareem Najma Khalil Hebatallah Hamed Ali Fehaid Ghali Alanazi Khalid F Alhabib
Lupus Sci Med
May 2024
Objective: This study examined the prevalence of major adverse cardiovascular events (MACE) among Saudi patients with SLE and the general population and considered factors associated with such outcomes were taken into consideration.
Methods: This is a cohort study evaluating the period prevalence of MACE from 2020 to 2023. The study used two datasets, namely the Saudi national prospective cohort for SLE patients and the Prospective Urban-Rural Epidemiology Study Saudi subcohort (PURE-Saudi) for the general population.
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry.
Piero Ruscitti Francesco Masedu Antonio Vitale Valeria Caggiano Ilenia Di Cola Hebatallah Hamed Ali Fatma Alibaz-Oner
Arthritis Rheumatol
July 2024
Article Synopsis
- This study evaluated the effectiveness of a systemic score in predicting severe outcomes in patients with Still disease, including the risk of mortality and severe complications like macrophage activation syndrome.
- Involving 597 patients, the study found that a higher systemic score significantly correlated with life-threatening outcomes, with scores of 7 or above indicating a greater risk.
- Key components that were most predictive of severe outcomes included liver and lung involvement, emphasizing the importance of these factors in managing Still disease.
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.
Paola Triggianese Antonio Vitale Giuseppe Lopalco Henrique Ayres Mayrink Giardini Francesco Ciccia Hebatallah Hamed Ali Moustafa Ali Saad Fatma Alibaz-Oner Alberto Balistreri
Intern Emerg Med
January 2024
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.
Paola Triggianese Antonio Vitale Giuseppe Lopalco Henrique Ayres Mayrink Giardini Francesco Ciccia Hebatallah Hamed Ali Moustafa Ali Saad Fatma Alibaz-Oner Alberto Balistreri
Intern Emerg Med
November 2023
Article Synopsis
- The study focuses on patients with Still's disease to identify clinical and laboratory signs associated with macrophage activation syndrome (MAS), a serious complication.
- Out of 414 patients examined, 39 (9.4%) developed MAS, with several significant variables like liver involvement and high ferritin levels linked to its occurrence.
- Multivariate analysis revealed that having hepatomegaly and monoarthritis were directly associated with MAS, while factors like a normal platelet count were protective against its development.